Freestone Grove Partners’s Dentsply Sirona XRAY Stock Holding History
Bought
Maintained
Sold
Other funds holding XRAY
AI
SCA
CB
Freestone Grove Partners's XRAY Position: Q2 2026 in Review
Freestone Grove Partners sold out of Dentsply Sirona (XRAY) in Q2 2026, closing a stake of 2,297,378 shares — an estimated $26.6M sold.
Freestone Grove Partners first reported a position in XRAY in Q1 2026 and held it in 1 quarter. The position peaked at $26.6M in Q1 2026. 374 funds tracked by Wall St. Rank hold XRAY as of Q2 2026.
- Freestone Grove Partners reported no remaining Dentsply Sirona position as of Q2 2026 after selling out during the quarter.
- Freestone Grove Partners sold 2,297,378 Dentsply Sirona shares in Q2 2026, an estimated $26.6M.
- Freestone Grove Partners first reported a position in Dentsply Sirona in Q1 2026 and held it in 1 quarter.
- Freestone Grove Partners's Dentsply Sirona position peaked at $26.6M in Q1 2026.
- 374 funds tracked by Wall St. Rank held Dentsply Sirona as of Q2 2026.
Based on Freestone Grove Partners's 13F filing for Q2 2026, filed 14 Aug 2026.